Literature DB >> 22245578

Metal binding dictates conformation and function of the amyloid precursor protein (APP) E2 domain.

Sven O Dahms1, Ina Könnig, Dirk Roeser, Karl-Heinz Gührs, Magnus C Mayer, Daniela Kaden, Gerd Multhaup, Manuel E Than.   

Abstract

The amyloid precursor protein (APP) and its neurotoxic cleavage product Aβ are key players in the development of Alzheimer's disease and appear essential for neuronal development and cell homeostasis in mammals. Proteolytic processing of APP is influenced by metal ions, protein ligands and its oligomerization state. However, the structural basis and functional mechanism of APP regulation are hitherto largely unknown. Here we identified a metal-dependent molecular switch located within the E2 domain of APP containing four evolutionary highly conserved histidine residues. Three X-ray structures of the metal-bound molecule were solved at 2.6-2.0 Å resolution. Using protein crystallographic and biochemical methods, we characterized this novel high-affinity binding site within the E2 domain that binds competitively to copper and zinc at physiological concentrations. Metal-specific coordination spheres induce large conformational changes and enforce distinct structural states, most likely regulating the physiological function of APP and its processing in Alzheimer's disease.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22245578     DOI: 10.1016/j.jmb.2011.12.057

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  31 in total

1.  Novel zinc-binding site in the E2 domain regulates amyloid precursor-like protein 1 (APLP1) oligomerization.

Authors:  Magnus C Mayer; Daniela Kaden; Linda Schauenburg; Mark A Hancock; Philipp Voigt; Dirk Roeser; Christian Barucker; Manuel E Than; Michael Schaefer; Gerhard Multhaup
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

Review 2.  Can the propensity of protein crystallization be increased by using systematic screening with metals?

Authors:  Raghurama P Hegde; Gowribidanur C Pavithra; Debayan Dey; Steven C Almo; S Ramakumar; Udupi A Ramagopal
Journal:  Protein Sci       Date:  2017-06-29       Impact factor: 6.725

3.  Amyloid precursor protein dimerization and synaptogenic function depend on copper binding to the growth factor-like domain.

Authors:  Frederik Baumkötter; Nadine Schmidt; Carolyn Vargas; Sandra Schilling; Rebecca Weber; Katja Wagner; Sebastian Fiedler; Wilfried Klug; Jens Radzimanowski; Sebastian Nickolaus; Sandro Keller; Simone Eggert; Klemens Wild; Stefan Kins
Journal:  J Neurosci       Date:  2014-08-13       Impact factor: 6.167

Review 4.  Regulation of the alternative β-secretase meprin β by ADAM-mediated shedding.

Authors:  Franka Scharfenberg; Fred Armbrust; Liana Marengo; Claus Pietrzik; Christoph Becker-Pauly
Journal:  Cell Mol Life Sci       Date:  2019-06-14       Impact factor: 9.261

Review 5.  Structural biology of cell surface receptors implicated in Alzheimer's disease.

Authors:  Stefan J Hermans; Tracy L Nero; Craig J Morton; Jonathan H Gooi; Gabriela A N Crespi; Nancy C Hancock; Chen Gao; Kenta Ishii; Jasmina Markulić; Michael W Parker
Journal:  Biophys Rev       Date:  2021-11-18

6.  Fluorescence resonance energy transfer links membrane ferroportin, hephaestin but not ferroportin, amyloid precursor protein complex with iron efflux.

Authors:  Adrienne C Dlouhy; Danielle K Bailey; Brittany L Steimle; Haley V Parker; Daniel J Kosman
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

Review 7.  The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin.

Authors:  Douglas G Peters; James R Connor; Mark D Meadowcroft
Journal:  Neurobiol Dis       Date:  2015-08-22       Impact factor: 5.996

8.  Comparative Effects of Metal-Catalyzed Oxidizing Systems on Carbonylation and Integrity of Therapeutic Proteins.

Authors:  Dmitry Kryndushkin; V Ashutosh Rao
Journal:  Pharm Res       Date:  2015-10-23       Impact factor: 4.200

9.  CK1δ-Derived Peptides as Novel Tools Inhibiting the Interactions between CK1δ and APP695 to Modulate the Pathogenic Metabolism of APP.

Authors:  Aileen Roth; Fabian Gärtner; Katja Mayer; Julian Beyrle; Irina König; Uwe Knippschild; Joachim Bischof
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

10.  The amyloid precursor protein (APP) does not have a ferroxidase site in its E2 domain.

Authors:  Kourosh Honarmand Ebrahimi; Christian Dienemann; Sandra Hoefgen; Manuel E Than; Peter-Leon Hagedoorn; Wilfred R Hagen
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.